Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDI-001 exploratory study in pediatric cerebral palsy due to PVL
jRCT2053210009Active, not recruiting
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Start
- Jul 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Open-label, single-arm trial of UDI-001 in cerebral palsy (CP) and periventricular leukomalacia (PVL), sponsored by Rohto Pharmaceutical Co., Ltd. Primary endpoint: Adverse events after treatment. Started Jul 2021; status: active, not recruiting.
02
Drugs
UDI-001
03
Conditions
cerebral palsy (CP)periventricular leukomalacia (PVL)
Beyond the preview
Go deeper on jRCT2053210009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2053210009.